Overjet’s AI program is the only one cleared by the FDA to detect, outline and quantify cavities and other pathologies, according to an April 2 news release from Cordental.
“Overjet’s AI helps our doctors make the best decisions for our patients,” Steven Jones, co-founder and chief growth officer of Cordental, said in the release. “We feel Overjet has augmented the clinical care our clinicians provide to our patients and will lead to better outcomes for our patients over time.”
The DSO went through a testing phase before the rollout to all of its practices.
Cordental supports practices across the Mid-Atlantic, Midwestern and Southeastern U.S., the release said.
At the Becker's 5th Annual Future of Dentistry Roundtable, taking place November 12–14 in Chicago, dental leaders and executives will gain insights into emerging technologies, practice growth strategies and the evolving landscape of dental care delivery, with a focus on innovation, patient experience and operational excellence. Apply for complimentary registration now.
